期刊文献+

HIV-1结构基因多重巢式RT-PCR方法检测 被引量:3

Simultenous detection of HIV-1 genes with multi-nested RT-PCR assay
原文传递
导出
摘要 目的建立一种简便、可靠的可用于诊断人类免疫缺陷病毒1型(HIV-1)感染的多重巢式逆转录-聚合酶链反应(RT-PCR)方法。方法针对广西壮族自治区HIV-1主要流行毒株pol、gag和env基因区设计PCR引物,建立同时扩增3个基因的多重巢式RT-PCR方法,检测118例HIV-1阳性样本和48例HIV-1阴性样本,并与免疫印迹法检测结果比较,对多重巢式PCR方法进行评价。结果多重巢式RT-PCR方法的检测下限为250 copies/mL,灵敏度和特异度分别为96.6%,97.9%,重复性为98.3%,与免疫印迹法的一致性为97.6%。结论本研究建立的多重巢式RT-PCR检测方法具有高灵敏度、高特异度、重复性好、快速等优点,可作为一种快速、简便、可靠的HIV-1感染辅助诊断方法。 Objective To develop an easy and reliable multi-nested RT-PCR assay for diagnosis of HIV-1 infection.Methods Several sets of PCR primers were designed to develop a multi-nested RT-PCR assay for amplification of gag,pol,and env gene of HIV-1 variants prevailing in Guangxi.Totally 118 HIV-positive samples and 48 HIV-negative samples were detected with the multi-nested RT-PCR assay and the detection results were compared to that of Western blot.Results The lowest limit of the multi-nested RT-PCR assay was 250 copies/mL and the sensitivity,specificity,and repeatability was 96.6%,97.9%,and 98.3%,respectively.The consistency between the multi-nested RT-PCR assay and Western blot assay was 97.6%.Conclusion A multi-nested RT-PCR assay with high sensitivity,specificity,repeatability,and time-saving was developed and could be applied for auxiliary diagnosis of HIV-1 infection.
出处 《中国公共卫生》 CAS CSCD 北大核心 2010年第9期1124-1125,共2页 Chinese Journal of Public Health
基金 广西高校百名中青年学科带头人资助项目(桂教人[2006]51号)
关键词 人类免疫缺陷病毒1型 多重巢式逆转录聚合酶链反应(RT-PCR) 诊断 感染 human immunodeficiency virus type 1(HIV-1) multi-nested RT-PCR diagnosis infection
  • 相关文献

参考文献7

二级参考文献20

  • 1杰伊A.利维.艾滋病病毒与艾滋病的发病机制.第2版[M].北京:科学出版社,2000.126-132.
  • 2[1]郑怀竞主编.临床基因扩增实验指南[M].北京:北京医科大学出版社,1999.20-23;67-92.
  • 3[4]Gibellini D,Vitone F,Gori E,et a1.Quantitative detection 0f human immunodeficieney virus type 1(HIV-1)viral load by SYBR green real-time RT-PCR technique in HIV-l seropositive patients [J].J Virol Methods,2004,115(2):183-189.
  • 4[5]Amendola A,Bordi L,Angeletti C,et al.Underevaluation of HIV-l plasma viral load by a commercially available assay in a cluster of patientsinfected with HIV-l A/G circulating recombinantform(CRF02)[J].J AcquirImmune Defic Syndr,2002,31(5):488-494.
  • 5[6]Bremer J,NowickiM,Beckner S,et al.Comparison 0f two amplification technologies for detection and quantitation of human immunodeficiency virus type Ⅰ RNA in the female genital tract.Division 0f AIDS Treatment Research Initiative 009 Study Team[J].J Clin Microbiol,2000,38(7)i 2665-2669.
  • 6Robertson DL,Sharp PM,McCutchan FE,et al.Recombination in HIV-1[J].Nature,1995,374:124-126.
  • 7杰伊A维利.艾滋病病毒与艾滋病的发病机制[M].第2版.北京:科学出版社,2000.127-131.
  • 8苏玲,邢辉,羊海涛,罗小光,邵一鸣.中国首例人类免疫缺陷病毒(HIV-1)A亚型毒株的鉴定[J].病毒学报,1997,13(3):265-268. 被引量:25
  • 9潘品良,曾常红,范秀娟,姚均,邢辉,冯毅,邵一鸣.人类免疫缺陷病毒膜蛋白基因(env)F亚型毒株在中国的首例发现[J].病毒学报,1999,15(2):97-101. 被引量:24
  • 10林鹏,王晔,曾常红,林矛.广东省HIV/AIDS监测系统的建立及其效果评价[J].中国性病艾滋病防治,2000,6(3):133-134. 被引量:13

共引文献57

同被引文献32

  • 1Tefferi A,Vardiman JW.Classification and diagnosis of mye-loproliferative neoplasms:The 2008 World Health Organizationcriteria and point-of-care diagnostic algorithms.Leukemia,2008;22(1):14-22.
  • 2Tefferi A,Skoda R,Vardiman JW.Myeloproliferative neoplasms:contemporary diagnosis using histology and genetics.Nat Rev ClinOncol,2009;6(11):627-637.
  • 3Alvarez RH,Kantarjian HM,Cortes JE.Biology of platelet-derived growth factor and its involvement in disease.Mayo ClinProc,2006;81(9):1241-1257.
  • 4Rathe M,Kristensen TK,Mller MB,et al.Myeloid neoplasmwith prominent eosinophilia and PDGFRΑrearrangement treatedwith imatinib mesylate.Pediatr Blood Cancer,2010;55(5):730-732.
  • 5Gotlib J,Cools J,Malone JM 3rd,et al.The FIP1L1-PDGFRαlpha fusion tyrosine kinase in hypereosinophilic syndromeand chronic eosinophilic leukemia:implications for diagnosis,classification,and management.Blood,2004;104(12):38-36.
  • 6Safley AM,Sebastian S,Collins TS,et al.Molecular andcytogenetic characterization of a novel translocation t(4;22)involving the breakpoint cluster region and platelet-derived growthfactor receptor-alpha genes in a patient with atypical chronicmyeloid leukemia.Genes Chromosomes Cancer,2004;40(1):44-50.
  • 7Beillard E,Pallisgaard N,van der Velden VH,et al.Evaluation ofcandidate control genes for diagnosis and residual disease detectionin leukemic patients using“real-time”quantitative reversetransc-riptase polymerase chain reaction(RQ-PCR)-A Europe againstcancer program.Leukemia,2003;17(12):2474-2486.
  • 8Pardanani A,Ketterling RP,Li CY,et al.FIP1L1-PDGFRΑineosinophilic disorders:prevalence in routine clinical practice,longterm experience with imatinib therapy,and a critical review ofthe literature.Leuk Res,2006;30(8):965-970.
  • 9Horard B, Vanacker M. Estrogen receptor-related receptors : orphan receptors desperately seeking a ligand [ J]. Mol Endocrinol,2003 ,31 :349 -357.
  • 10Ariazi EA,Clark GM,Mertz JE. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers,respectively,in human breast cancer [J]. Cancer Res,2002,62:6510 -6518.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部